Ravelcare IPO Analyzed: Key Details and Investment Considerations

Ravelcare, a beauty and personal care brand, is going public through an Initial Public Offering (IPO). This means the company is selling shares to the public for the first time. The IPO opens for subscriptions on December 1, 2025, and could be a good opportunity for investors to get in on the company’s growth. It’s important to understand how this IPO works before investing.

Key Points

• Ravelcare’s IPO seeks ₹24.1 crore, focusing on growth and expansion.
• Investors can bid for shares between ₹123 and ₹130 per share.
• Minimum investment for retail investors: ₹260,000 (two lots).
• Qualified Institutional Buyers (QIBs) get 50%, Retail 35%, NIIs 15%.
• The IPO closes on December 3, 2025, with allotment finalized Dec 4th.
• Shares will list on the BSE SME platform, tentatively, Dec 8th, 2025.

What’s the IPO about? The company is raising money – a total of ₹24.1 crore. This money will be used to boost their marketing efforts and build a new factory in Amravati, India. These expansions are key to growing the business.

How much can I invest? Investors can purchase shares in lots of 1,000 shares. The price of each share will be between ₹123 and ₹130. A retail investor needs to invest at least ₹260,000 to buy two lots. High-net-worth individuals can buy larger quantities.

When does it happen? The subscription period for the IPO will run for three days, tentatively closing on December 3, 2025. The final decision on which investors get shares will be made on December 4th. Finally, the shares will be listed on the BSE SME platform, likely on December 8, 2025.

Who’s involved? Kfintech Technologies is the company handling the IPO process, and Marwadi Chandrana Intermediaries Brokers is the lead manager. These organizations ensure the IPO runs smoothly.

How are the shares doing now? On November 26th, the unlisted shares of Ravelcare were trading at ₹146, showing a 12.3% increase from the upper price band. This suggests investors are optimistic about the company’s prospects.

Financial Performance: Ravelcare reported strong financial results. In FY25, revenue increased by 13% to ₹24.97 crore, with earnings before interest, tax, depreciation and amortisation reaching ₹6.81 crore and profit after tax at ₹5.25 crore.

“A successful IPO signifies Ravelcare’s potential for continued growth and value creation for its shareholders.”